Beijing 2016 - Programme
Our conference format is unique. The programme is interactive with a wide range of presentation formats, including plenary and breakout sessions. The content is relevant, innovative and enriching, and you will get the latest updates within the industry. Evening networking event provides an informal occasion to connect with fellow attendees. There will be simultaneous translation at the conference (EN>CN, CN>EN).
Programme
Tuesday
Registration and welcome coffee
A starter session on GS1 standards
Introduction to global standards for Identify, Capture and Share
Mr. Jackie Du, Assistant Director, Promotion Dept., GS1 China
Opening Plenary Session: Pharmaceuticals/Traceability from manufacturer to patient
Traceability is an ubiquitous requirement in Healthcare – to improve patient safety through visibility in many business processes
Opening remarks and welcome to the conference
Ms. Ulrike Kreysa, Vice-President Healthcare, GS1 Global Office
Mr. Miguel Lopera, President and CEO, GS1 Global Office
Welcome from GS1 China
Mr. Zhang Chengai, President and CEO, GS1 China
Official welcome
Senior Officer, Standardisation Administration of the People's Republic of China (SAC)
USA DSCSA requirements and implementation plans
Ms. Connie Jung, Senior Advisor for Policy, U.S. Food and Drug Administration (confirmed)
Pharmaceutical traceability in China
Ms. Gu Lihong, Senior Consultant, The Partnership For Safe Medicines (PSM) China (confirmed)
Traceacility from global manufacturer's perspective
Mr. Mike Dethick, Managing Director, The R&D-based Pharmaceutical Association Committee (RDPAC), China (confirmed)
Coffee break
EU Falsified Medicine Directive
Mr. Jerome Lepeintre, Minister Counsellor for Health and Food Safety, Delegation of the European Union to China and Mongolia (confirmed)
Evolution of traceability in Argentina
Dr. Maximiliano Derecho, Legal Advisor, National Administration of Drugs, Food and Medical Devices (ANMAT), Argentina (confirmed)
Korea pharmaceuticals serialisation policy & national traceability system
Ms. Kyoungja Lee, General Director, Pharmaceutical information management division of KPIS, Health Insurance Review and Assessment Service, Korea (confirmed)
Introduction to charity
Mr. Liu Dong, President, Beijing Chunmiao Children’s Aid Foundation, Director, Division of Cardiac Surgery, Beijing United Family Hospital and Clinics (BJU)
GS1 Healthcare supports a local charity with 5 EUR for every received feedback form.
Introduction to afternoon session
Introduction to presentations for the poster session
Networking lunch
Implementation Reality Sessions – Round 1 (register for one of the three)
Three concurrent breakout sessions on traceability or public policy (medical devices). Participants can choose from three sessions - session 1 and 2 will be repeated.
-
1. Pharmaceutical traceability – what does it mean for the manufacturers and wholesalers
A mix of manufacturers and wholesalers will each present their respective approach to traceability, leveraging a combination of GS1 standards and product serialization. A panel discussion will round out the session, including a regulator’s perspective.
Panellists: Ms. Peggy Staver, Director, Product Integrity, Pfizer; Mr. Jeffrey Denton, Senior Director, Secure Supply Chain, AmerisourceBergen Corporation; Mr. Michael Rose, Vice President, Supply Chain Visibility, Johnson & Johnson Supply Chain; Mr. Scott Mooney, Vice President Distribution Operations, McKesson; Dr. Maximiliano Derecho, Legal Advisor, ANMAT, Argentina
Moderator: Mr. Craig Alan Repec, Senior Manager, Supply Chain Visibility, EPCIS & RFID, GS1 Global Office -
2. Traceability– implementation and benefits for hospitals and retail pharmacies
Providers who have implemented GS1 standards for traceability in the care giving environment will share their experiences and advice: where to start, why, drivers, sponsorship and funding, the positive results and challenges
Chair: Mr. Jean-Michel Descoutures, Chief of Pharmacy, Centre Hospitalier Victor DupouyPanellists: Mr. Feargal Mc Groarty, National Haemophilia System Project Manager, St. James's Hospital, Ireland; Mr. Justin Bitter, Business Manager, Bernhoven Hospital, Netherlands; Mr. Peter Helmbaek, Senior Consultant, Amgros I/S, Denmark -
3. Public Policy: Medical Devices
Regulatory requirements and initiatives from around the world related to medical devices - normally a closed group; it is only open for this session.
Moderators: Ms. Géraldine Lissalde-Bonnet, Public Policy Director, GS1 Global Office; Ms. Jackie Rae Elkin, Global Process Owner, Standard Product Identification, Global Regulatory Affairs, Medtronic, Inc.
Coffee break
Implementation Reality Sessions – Round 2 (repeat of 1 and 2, register for one of the two)
-
1. Traceability – implementation and benefits for hospitals and retail pharmacie
Chair: Mr. Jean-Michel Descoutures, Chief of Pharmacy, Centre Hospitalier Victor DupouyPanellists: Mr. Feargal Mc Groarty, National Haemophilia System Project Manager, St. James's Hospital, Ireland; Mr. Justin Bitter, Business Manager, Bernhoven Hospital, Netherlands; Mr. Peter Helmbaek, Senior Consultant, Amgros I/S -
2. Pharmaceutical traceability – what does it mean for the manufacturers and wholesalers
Panellists: Ms. Peggy Staver, Director, Product Integrity, Pfizer; Mr. Jeffrey Denton, Senior Director, Secure Supply Chain, AmerisourceBergen Corporation; Mr. Michael Rose, Vice President, Supply Chain Visibility, Johnson & Johnson Supply Chain; Mr. Scott Mooney, Vice President Distribution Operations, McKesson; Dr. Maximiliano Derecho, Legal Advisor, ANMAT, Argentina
Moderator: Mr. Craig Alan Repec, Senior Manager, Supply Chain Visibility, EPCIS & RFID, GS1 Global Office
Poster reception
Discover the latest GS1 Healthcare implementations and initiatives developed by GS1 Member Organisations – vote for the best poster
International Government Healthcare Supply Chain Think Tank
(Invitation only)
Open to international government healthcare organisations – discussions will be held under the Chatham House Rule
Thursday
Welcome coffee
Plenary session – Unique Device Identification (UDI) and regulatory Track & Trace initiatives for Medical Devices
UDI aims to establish a single device identification system that is consistent, unambiguous and globally standardised. The session provides an overview of the status on UDI across the world and informs on other initiatives regarding track & trace for medical devices.
Latest advances CFDA made on regulations for UDI
Ms. Li Jun, Division Director of the Department of Medical Device Registration, CFDA
The new MD regulation in Europe
Mr. Salvatore Scalzo, Policy and Legal Officer, DG for Internal Market, Industry, Entrepreneurship and SMEs, Health Technology and Cosmetics, European Commission (confirmed)
Medical Device Track and Trace System in Turkey Cooperated by Turkish Medicines and Medical Devices Agency and The Scientific and Technological Research Council of Turkey
Mr. Ömer Özkan, Institute deputy manager, TÜBITAK BILGEM Software Technologies Research Institute (confirmed)
UDI regulation & implementation in the U.S.
Mr. Jay Crowley, Vice President and UDI Practice Lead, USDM Life Sciences (confirmed)
Regulation on traceability of medical devices in Argentina
Dr. Maximiliano Derecho, Legal Advisor, ANMAT, Argentina (confirmed)
Coffee break
UDI implementation from manufacturer's view
Ms. Eva Chow, IT Director, Medtronic (confirmed)
UDI Implementation in Shanghai Shuguang Hospital
Mr. Zhou Hua, President, Shanghai Shuguang Hospital, China (confirmed)
Global standards for an international company
Ms. Kathryn E. Wengel, Worldwide Vice-President & Chief Supply Chain Officer, Management committee member, Johnson & Johnson (confirmed)
Introduction to afternoon sessions
Networking lunch
Implementation reality sessions - round 1 (register for one of the three).
Three concurrent breakout sessions on how to implement UDI or public policy (Pharmaceuticals and vaccines). Participants can choose from three sessions - session 1 and 2 will be repeated:
-
1. Implementation sessions on UDI - marking/labelling
Need a better understanding of the steps involved in the implementation of the Automatic Identification and Data Capture (AIDC) based identification and marking of medical devices for the U.S. FDA UDI rule as well as other global UDI initiatives? Join this session to learn about the challenges and successes from our panellists as they share their practical experiences and answer your UDI AIDC implementation questions.
Panellists: Mr. Chuck Biss, Senior Director, AIDC Healthcare, GS1 Global Office; Ms. Jackie Rae Elkin, Global Process Owner, Standard Product Identification, Global Regulatory Affairs, Medtronic, Inc; Mr. Tom Werthwine, Director, Industry Standards, Supply Chain Visibility, Johnson & Johnson; Mr. Stan Malinowski, Mgr Mfg Sys Integration, UDI Lead GS1 Standards & Marking Technologies, Strategic Project Management, Medtronic
-
2. Implementation sessions on UDI - Data/GDSN
Master Data Management is one of the most challenging areas relating to the implementation of the UDI regulation and Global Data Synchronisation. It involves the management of information at global and local levels. Inconsistent, incomplete and incorrect data increase the risk of patient safety errors and the cost of healthcare across the entire supply chain. The ultimate value of data quality translates to patient safety and improved lives for the caregivers. Join this session as panellists share their experiences in getting ready to provide data to the FDA’s GUDID and the lessons learned from their GDSN implementation success stories.
Panellists: Mr. Nick Manzo, Global Omni-Channel Commercial Lead, 1WorldSync; Ms. Catherine Koetz, Industry Manager - Healthcare, GS1 Australia; Fengming Mao, Assistant Director, GDSN, IT Dept., GS1 China; Mr. Peter Alvarez, Sr. Director Master Data Management, GS1 Global Office
-
3. Public policy: Pharmaceuticals and vaccines
Regulatory requirements and initiatives from around the world related to pharmaceuticals and vaccines - normally a closed group; it is only open for this session.
Moderators: Ms. Géraldine Lissalde-Bonnet, Public Policy Director, GS1 Global Office; Ms. Peggy Staver, Director, Product Integrity, Pfizer, Co-Chair Public Policy work group
Coffee break
Implementation reality sessions - round 2 (repeat of 1 and 2, register for one of the two)
-
1. Implementation sessions on UDI - Data/GDSN
Panellists: Mr. Nick Manzo, Global Omni-Channel Lead, 1WorldSync; Ms. Catherine Koetz, Industry Manager - Healthcare, GS1 Australia; Fengming Mao, Assistant Director, GDSN, IT Dept., GS1 China; Mr. Peter Alvarez, Sr. Director Master Data Management, GS1 Global Office -
2. Implementation sessions on UDI - marking/labelling
Panellists: Mr. Chuck Biss, Senior Director, AIDC Healthcare, GS1 Global Office; Ms. Jackie Rae Elkin, Global Process Owner, Standard Product Identification, Global Regulatory Affairs, Medtronic, Inc; Mr. Tom Werthwine, Director, Industry Standards, Supply Chain Visibility, Johnson & Johnson; Mr. Stan Malinowski, Mgr Mfg Sys Integration, UDI Lead GS1 Standards & Marking Technologies, Strategic Project Management, Medtronic
Networking event
Wednesday
Welcome coffee
Plenary session – Hospital implementation
In this session providers who have implemented GS1 standards in the care giving environment will share their experiences and advice
Global standards - the foundation for developing hospital information system
Mr. Wang Jian, Director of medical affair of medical support department, The General Hospital of the People's Liberation Army (confirmed)
Implementation of standardised traceability system in Japan
Dr. Chikayuki Ochiai, M.D., D.M.Sc., Professor of Tokyo Healthcare University, Honorary CEO of NTT Medical Center, Tokyo (confirmed)
National Drug Information Sharing in the Thailand Health Care Supply Chain
Assoc. Prof. Dr. Duangpun Kritchanchai, Healthcare Supply Chain Excellence Centre, Centre of Logistics Management, Faculty of Engineering, Mahidol University, Thailand (confirmed)
GS1 implementation in Shanghai East Hospital
Mr. Xu Zhaohui, Vice President, Shanghai East Hospital, China
Coffee break
Plenary session - Hospital implementation - continued
-
HPAC Award
The GS1 Healthcare Provider Advisory Council (HPAC) provides two awards for:
1. an individual who has contributed extensively to furthering GS1 Healthcare's work efforts over the years;
2. a provider organisation that has implemented GS1 standards for at least one process in their organisation
Presentation of winner of the 'Provider Recognition Award'
Presentation of winner of the 'Provider Implementation Best Case Study Award'
The New Era of Healthcare
Mr. Ashley Brooks, NHS Patient Champion, UK (confirmed)
Invitation to the next conference in Berlin, Germany
Mr. Juergen Schmitz, Head of Sales, GS1 Germany
Closing remarks – GS1 Healthcare Tri-Chairs
Travel to Shanghai (optional, by registration only)
Site visits at Shanghai Shuguang Hospital or Shanghai East Hospital on Friday 28 October.
Friday
Departures from Grand Kempinski Hotel Shanghai
Introduction
Management system in operating theatre
Management system in hospital pharmacy
Back to hotel
Lunch